But can you update this committee on your efforts to implement a policy like this through any type of executive rulemaking? I think. Are we in rule making on it? We will have an announcement soon and we're happy to work with you on [the Ensuring Patient Access to Critical Breakthroughs Product act]. it. This is really important and builds on the success from the Trump first administration. There is, as I'm learning too, FDA and cms, they operate in parallel, they operate in tandem. (02:58–03:02)
CLAIM
Asserts that an announcement regarding the Ensuring Patient Access to Critical Breakthroughs Product act will be made soon.
This is an excerpt from a raw transcript. The assertions have not been audited or verified. Tap the video to view the source footage and understand the context.
